top of page

NuvOx Pharma Announces Appointment of Jon S. Saxe to Its Board of Directors

"We are honored and excited to have Jon Saxe join our board," said Evan Unger MD, President and CEO of NuvOx. "His broad knowledge of the industry and years of experience both as an executive and in corporate governance will serve NuvOx well as it continues to grow in the coming years. The other members of the board and I are very much looking forward to working with him." Click here to read more.

Recent Posts

See All

Tucson, AZ, May 16th, 2022 - NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of prepara

Tucson, AZ, May 9th, 2022 – NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases whe

bottom of page